AGM
CLB icon

Alpine Global Management’s Core Laboratories CLB Stock Holding History

Alpine Global Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-22,513
Closed -$848K – 264
2019
Q4 		$848K Buy
+22,513
New +$1.01M 0.18% 107

Other funds holding CLB

VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Alpine Global Management's CLB Position: Q1 2020 in Review

Alpine Global Management sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 22,513 shares — an estimated $848K sold.

Alpine Global Management first reported a position in CLB in Q4 2019 and held it in 1 quarter. The position peaked at $848K in Q4 2019. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

  • Alpine Global Management reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
  • Alpine Global Management sold 22,513 Core Laboratories shares in Q1 2020, an estimated $848K.
  • Alpine Global Management first reported a position in Core Laboratories in Q4 2019 and held it in 1 quarter.
  • Alpine Global Management's Core Laboratories position peaked at $848K in Q4 2019.
  • 207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on Alpine Global Management's 13F filing for Q1 2020, filed 9 Apr 2020.